Acute Renal Injury
16
2
2
9
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (16)
Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
Recombinant Human C1 Esterase Inhibitor (Conestat Alfa) in the Prevention of Acute Ischemic Cerebral and Renal Events After Transcatheter Aortic Valve Implantation
Kidney Precision Medicine Project
Dialyzing Wisely - Improving the Delivery of Acute Renal Replacement Therapy to Albertans
Investigation of the Relationship Between Blood Transfusion Volume and Development of Renal Failure in Pediatric Patients Undergoing Cardiovascular Surgery
Acute Kidney Injury in Intensive Care Patients
Renal and Cardiac Risk Factors of AKI After Liver Transplantation
Postoperative Kidney Functions in Geriatric Major Gynecologic-Oncologic Surgery
Acute Kidney Injury in Critically Ill Patients
Acute Renal Injury After Major Elective Non-Cardiac Surgery
Kidney Protection Using the RenalGuard® System in Cardiac Surgery
Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)
Dexmedetomidine on Pediatric Heart Operation
Minimizing Contrast Utilization With IVUS Guidance in Coronary Angioplasty to Avoid Acute Nephropathy
Short Term Spironolactone for Prevention of Acute Kidney Injury After Cardiac Surgery
Acute Renal Injury Associated Contrast in Intensive Care Unit Patients